ADDvise Group AB (publ) ("ADDvise" or the "Company") announces today that the Company has successfully placed a subsequent senior secured bond issue (the “Subsequent Bond Issue") in an amount of SEK 150 million under the Company’s existing senior secured bond framework with ISIN SE0015222088. Following completion of the Subsequent Bond Issue, the outstanding amount under the senior secured bonds will be SEK 650 million.
The transaction was significantly oversubscribed and placed at a price of 100.0% of par.
Completion of the Subsequent Bond Issue is subject to inter alia the approval of the requested amendments to the terms and conditions of the bonds pursuant to the written procedure that was initiated on 21 November 2022. Provided that such approval is granted, settlement is expected to occur no later than 16 December 2022.
Pareto Securities AB acted as sole bookrunner and Roschier Advokatbyrå as legal advisor in connection with the subsequent bond issue.
For further information, please contact:
Rikard Akhtarzand, CEO
+46 765-25 90 71
rikard.akhtarzand@addvisegroup.se
Hanna Myhrman, General Counsel
+46 709-82 92 23
hanna.myhrman@addvisegroup.se
Important information:
This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on 23 November 2022 at 16:55 CET.
About ADDvise Group
ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The Group consists of two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expanding the business – both geographically and product-wise. ADDvise Group’s shares are listed on Nasdaq First North Premier Growth Market and Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.